tiprankstipranks
Aspen Aerogels Inc (ASPN)
:ASPN

Aspen Aerogels (ASPN) AI Stock Analysis

Compare
1,171 Followers

Top Page

AS

Aspen Aerogels

(NYSE:ASPN)

61Neutral
Aspen Aerogels demonstrates strong financial performance with significant revenue growth and improved profitability. However, the stock is experiencing technical weakness, and its high valuation presents potential risks. The cautious outlook for 2025 and halting of Plant II construction adds to uncertainty. While the company is well-positioned in its industry, investors should consider these risks alongside its financial strengths.
Positive Factors
Cash generation
Aspen Aerogels is now positioned with a much less capital intensive business with a strong balance sheet, an outlook for improved cash generation, and a share buyback authorization hinted at in the near-term.
Financial performance
Aspen reported 4Q24 results that mostly beat consensus estimates, with total revenue up 46% annually and representing its fifth consecutive quarter of positive adjusted EBITDA.
OEM partnerships
The 8th OEM award announced with Volvo trucks.
Negative Factors
Division growth concerns
There is a loss of conviction in the EV Thermal Barriers division's ability to sustain growth and margins.
EV market demand
Weaker EV demand results in a reset for 2025 with management electing to end construction at the Georgia plant.
Guidance and visibility
Aspen Aerogels guided revenue, Adjusted EBITDA and EPS below the Street for 1Q, and withheld providing guidance for FY25 citing lack of visibility into production demand.

Aspen Aerogels (ASPN) vs. S&P 500 (SPY)

Aspen Aerogels Business Overview & Revenue Model

Company DescriptionAspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.
How the Company Makes MoneyAspen Aerogels generates revenue through the sale of its proprietary aerogel insulation products. The company serves a diverse range of industries including oil and gas, petrochemical, building materials, and automotive sectors. Key revenue streams come from direct product sales to industrial customers and distributors. Aspen Aerogels also engages in strategic partnerships and collaborations with major industry players to expand its market reach and enhance its product offerings. The company's pricing strategy and revenue are influenced by factors such as raw material costs, manufacturing efficiencies, and market demand for energy-efficient insulation solutions.

Aspen Aerogels Financial Statement Overview

Summary
Aspen Aerogels is on a positive financial trajectory, showing strong revenue growth and improved profitability metrics. While there is a solid equity base with low leverage, the company needs to focus on enhancing ROE and generating positive free cash flow to strengthen financial health further. The improvements in profitability and revenue growth are encouraging, positioning the company well within the construction industry.
Income Statement
78
Positive
Aspen Aerogels has shown significant improvement in its financial performance over the TTM. The gross profit margin stands at 40.4%, indicating efficient production cost management. The net profit margin has turned positive to 2.95% from negative figures in previous years, reflecting improved overall profitability. Revenue growth rate is robust at 89.6%, showcasing strong top-line growth. EBIT and EBITDA margins are at 12.64% and 31.55% respectively, highlighting operational efficiency gains. Although past years showed losses, the current trajectory is positive.
Balance Sheet
70
Positive
The balance sheet reflects a stable financial structure with a low debt-to-equity ratio of 0.17, indicating conservative leverage. Return on Equity (ROE) at 2.17% shows an initial positive return, though still modest. The equity ratio is strong at 68.65%, signifying a solid equity base. The company has been able to maintain a healthy cash position, aiding in financial stability. However, the company should continue to focus on improving ROE to enhance shareholder value.
Cash Flow
65
Positive
Aspen Aerogels has demonstrated improved cash flow management. The free cash flow growth rate has improved but remains negative, indicating ongoing investments or working capital needs. Operating cash flow to net income ratio is 0.74, suggesting reasonable cash generation relative to income. Despite negative free cash flow, the company has been able to finance its operations through positive financing cash flow, likely from equity or debt issuance. Continued focus on generating positive free cash flow is recommended.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
452.70M238.72M180.36M121.62M100.27M
Gross Profit
182.90M56.92M4.98M9.94M14.59M
EBIT
54.53M-49.20M-79.25M-40.60M-21.57M
EBITDA
49.57M-22.31M-65.77M-25.81M-11.37M
Net Income Common Stockholders
13.38M-45.81M-86.23M-27.88M-11.85M
Balance SheetCash, Cash Equivalents and Short-Term Investments
220.88M139.72M281.33M76.56M16.50M
Total Assets
895.14M703.05M646.57M182.95M97.42M
Total Debt
102.42M138.77M126.66M15.24M8.31M
Net Debt
-118.46M-951.00K-154.68M-61.33M-8.19M
Total Liabilities
280.44M214.99M203.23M54.55M29.57M
Stockholders Equity
614.71M488.06M447.44M128.41M67.85M
Cash FlowFree Cash Flow
-40.71M-218.07M-272.37M-32.41M-13.34M
Operating Cash Flow
45.55M-42.61M-94.40M-18.63M-9.92M
Investing Cash Flow
-86.26M-175.46M-177.97M-13.78M-3.42M
Financing Cash Flow
122.02M75.48M478.37M92.47M26.20M

Aspen Aerogels Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.39
Price Trends
50DMA
9.00
Negative
100DMA
11.46
Negative
200DMA
17.98
Negative
Market Momentum
MACD
-0.61
Negative
RSI
29.43
Positive
STOCH
18.17
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASPN, the sentiment is Negative. The current price of 6.39 is below the 20-day moving average (MA) of 7.23, below the 50-day MA of 9.00, and below the 200-day MA of 17.98, indicating a bearish trend. The MACD of -0.61 indicates Negative momentum. The RSI at 29.43 is Positive, neither overbought nor oversold. The STOCH value of 18.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ASPN.

Aspen Aerogels Risk Analysis

Aspen Aerogels disclosed 72 risk factors in its most recent earnings report. Aspen Aerogels reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Aspen Aerogels Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
RPRPM
77
Outperform
$14.67B22.5425.61%1.70%0.12%24.30%
OCOC
71
Outperform
$12.20B19.3612.63%1.75%13.41%-44.36%
KOKOP
65
Neutral
$571.35M11.3310.61%1.00%-2.88%-41.29%
PPPPG
65
Neutral
$24.39B18.0119.13%2.50%-4.59%11.09%
62
Neutral
$8.05B13.604.04%3.11%3.70%-14.19%
61
Neutral
$540.25M41.092.43%89.64%
61
Neutral
$866.58M54.682.43%-0.59%-0.85%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ASPN
Aspen Aerogels
6.39
-10.37
-61.87%
KOP
Koppers Holdings
28.00
-26.00
-48.15%
OC
Owens Corning
142.82
-21.45
-13.06%
PPG
PPG Industries
109.35
-29.25
-21.10%
PRLB
Proto Labs
35.04
0.67
1.95%
RPM
RPM International
115.68
0.70
0.61%

Aspen Aerogels Earnings Call Summary

Earnings Call Date: Feb 12, 2025 | % Change Since: -45.62% | Next Earnings Date: Apr 30, 2025
Earnings Call Sentiment Neutral
Aspen Aerogels reported strong revenue growth and profitability in 2024, driven by the success of its PyroThin Thermal Barriers and Energy Industrial segments. However, the decision to halt construction of Plant II and a cautious outlook for 2025, coupled with potential tariff challenges, present notable concerns.
Highlights
Record Revenue Growth
Aspen Aerogels reported a revenue of $453 million for 2024, representing a 90% increase compared to the previous year.
Positive Adjusted EBITDA
The company achieved an adjusted EBITDA of $90 million in 2024, a significant turnaround from a negative $23 million in 2023.
PyroThin Thermal Barriers Success
Revenue from PyroThin Thermal Barriers grew to $307 million in 2024, up from $110 million in 2023, with new design awards from Volvo Truck and Mercedes-Benz.
Energy Industrial Business Milestones
The Energy Industrial segment achieved a record Q4 revenue of $53 million and a gross margin exceeding 40%, largely supplied by the External Manufacturing Facility (EMF).
Strong Financial Position
The company ended 2024 with over $220 million in cash on the balance sheet, providing financial flexibility for future strategic initiatives.
Lowlights
Reduced Outlook for 2025
Aspen Aerogels is providing guidance only for Q1 2025 due to uncertainties in the macro environment, reflecting a cautious approach to revenue expectations.
Construction Halted on Plant II
The company decided to cease construction of Plant II in Statesboro, Georgia, impacting long-term capacity expansion plans.
Potential Impact of Tariffs
The company faces potential risks from tariffs on Energy Industrial products delivered from the EMF to the U.S., though mitigating strategies are in place.
Q1 2025 Revenue Guidance
The revenue guidance for Q1 2025 is $75 million to $95 million, reflecting a significant drop from previous quarters.
Company Guidance
During the Aspen Aerogels Q4 2024 earnings call, the company reported significant achievements and provided guidance for 2025. Aspen Aerogels achieved a record revenue of $453 million for the year, which represented a 90% increase from the previous year, and adjusted EBITDA of $90 million, up from a negative $23 million in 2023. The PyroThin Thermal Barriers business grew substantially, with revenue reaching $307 million, driven by new OEM awards, including a significant design award from Volvo Truck. Meanwhile, the Energy Industrial segment had a strong year, with Q4 revenue of $53 million and gross margins exceeding 40%. Looking ahead, Aspen Aerogels has decided to cease construction of Plant II in Georgia, opting instead to maximize capacity at its East Providence facility and leverage a flexible external manufacturing strategy. For Q1 2025, the company anticipates revenue between $75 million and $95 million, with adjusted EBITDA ranging from breakeven to $15 million. Aspen Aerogels plans to reduce fixed costs by at least $8 million per quarter and aims for long-term growth while maintaining strong gross margins and profitability.

Aspen Aerogels Corporate Events

Business Operations and StrategyFinancial Disclosures
Aspen Aerogels Achieves Financial Turnaround in FY 2024
Positive
Feb 12, 2025

Aspen Aerogels reported a significant financial turnaround in FY 2024 with revenues increasing by 90% to $452.7 million, and a net income of $13.4 million compared to a loss in the previous year. The company also secured a contract to supply PyroThin Thermal Barriers for Volvo Truck and optimized its manufacturing strategy by utilizing external facilities, halting the Statesboro plant project, and maximizing its existing plant’s capacity to meet growing demand.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.